MXPA05009447A - Vacunas bovinas con adyuvante. - Google Patents

Vacunas bovinas con adyuvante.

Info

Publication number
MXPA05009447A
MXPA05009447A MXPA05009447A MXPA05009447A MXPA05009447A MX PA05009447 A MXPA05009447 A MX PA05009447A MX PA05009447 A MXPA05009447 A MX PA05009447A MX PA05009447 A MXPA05009447 A MX PA05009447A MX PA05009447 A MXPA05009447 A MX PA05009447A
Authority
MX
Mexico
Prior art keywords
adjuvanted
shedding
coli
provides
bovine vaccines
Prior art date
Application number
MXPA05009447A
Other languages
English (en)
Inventor
Li Wumin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA05009447A publication Critical patent/MXPA05009447A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invencion proporciona una composicion de vacuna segura y efectiva contra propagacion de E. coli 0157:H7. Un componente activo inmunogenicamente E. coli 0157:H7, un adyuvante tal como un aceite metabolizable, y un portador aceptable farmacologicamente son formulados en una vacuna inmunizante. La invencion tambien proporciona un metodo para la prevencion o mejora de propagacion de E. coli 0157:H7.
MXPA05009447A 2003-03-12 2004-03-05 Vacunas bovinas con adyuvante. MXPA05009447A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45418203P 2003-03-12 2003-03-12
PCT/US2004/006941 WO2004080400A2 (en) 2003-03-12 2004-03-05 Adjuvanted bovine vaccines

Publications (1)

Publication Number Publication Date
MXPA05009447A true MXPA05009447A (es) 2005-11-23

Family

ID=32990880

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009447A MXPA05009447A (es) 2003-03-12 2004-03-05 Vacunas bovinas con adyuvante.

Country Status (12)

Country Link
US (1) US20040180060A1 (es)
EP (1) EP1601375A2 (es)
JP (1) JP2006519880A (es)
AR (1) AR043539A1 (es)
AU (2) AU2004220543A1 (es)
BR (1) BRPI0408249A (es)
CA (1) CA2517498A1 (es)
CO (1) CO5660272A2 (es)
MX (1) MXPA05009447A (es)
NZ (1) NZ542253A (es)
TW (1) TWI350174B (es)
WO (1) WO2004080400A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465331C2 (ru) * 2003-10-31 2012-10-27 Дзе Юниверсити Оф Бритиш Коламбиа Бактериальные факторы вирулентности и варианты их применения
MX2010005014A (es) * 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
MX2012004133A (es) * 2009-10-07 2012-05-08 Wyeth Llc Composiciones que comprenden adyuvante, macrolido y antigeno proteico y procedimientos de uso de las mismas.
WO2012157699A1 (ja) * 2011-05-18 2012-11-22 味の素株式会社 動物用免疫賦活剤、それを含む飼料及びその製造方法
CA3005608C (en) * 2013-09-19 2020-06-30 Zoetis Services Llc Water-in-oil emulsions comprising immunostimulatory oligonucleotides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827028A (ja) * 1994-07-21 1996-01-30 Nippon Seibutsu Kagaku Kenkyusho 油性アジュバント及びアルミニウムゲルアジュバントからなる動物用ワクチン製剤
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
JP4282804B2 (ja) * 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
EP1195162B1 (en) * 1999-03-03 2008-06-04 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
DE60025522T2 (de) * 1999-11-29 2006-07-06 Akzo Nobel N.V. Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
EP1316314A4 (en) * 2000-08-31 2004-12-29 Kitasato Inst PREPARATION OF A VACCINE CONTAINING FATTY ACID AS A COMPOUND
US7300659B2 (en) * 2001-01-04 2007-11-27 University Of Saskatchewan Enterohemorrhagic Escherichia coli vaccine
PT1372708E (pt) * 2001-02-13 2008-09-29 Us Gov Sec Army Vacina para imunização transcutânea
EP1314359A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals

Also Published As

Publication number Publication date
EP1601375A2 (en) 2005-12-07
CO5660272A2 (es) 2006-07-31
CA2517498A1 (en) 2004-09-23
AU2004220543A1 (en) 2004-09-23
JP2006519880A (ja) 2006-08-31
WO2004080400A2 (en) 2004-09-23
TW200423956A (en) 2004-11-16
NZ542253A (en) 2008-07-31
AR043539A1 (es) 2005-08-03
TWI350174B (en) 2011-10-11
US20040180060A1 (en) 2004-09-16
AU2010202344A1 (en) 2010-07-01
WO2004080400A3 (en) 2005-03-03
BRPI0408249A (pt) 2006-03-01

Similar Documents

Publication Publication Date Title
MXPA04000680A (es) Vacuna para virus west nile.
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
HK1121382A1 (en) Adjuvant compositions for enhancing immune responses to polynucleotide- based vaccines
WO2007030810A3 (en) Multiparameter whole blood monitor and method
RS52188B (en) A PSYCHI VACCINE FOR THE PROTECTION OF ERLIHIOSIS
EP1467771A4 (en) MYCOBACTERIAL VACCINE
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
MXPA05009447A (es) Vacunas bovinas con adyuvante.
EP1395283A4 (en) HETEROLOGOUS PROTECTION INDUCED BY IMMUNIZATION WITH INVAPLEX VACCINE
BR0209673B1 (pt) sistema tensoativo, composiÇço adjuvante para a modificaÇço das propriedades reolàgicas de um sistema tensoativo, e mÉtodo de espessamento de um sistema tensoativo.
EP1581638A4 (en) ANTIGENS P153 AND P156 FOR THE IMMUNODIAGNOSIS OF CANINE AND HUMAN EHRLICHIOSES AND USES THEREOF
UA86405C2 (ru) Способ вакцинации против инфекции семенников, вызванной вирусом бычьей вирусной диареи
WO2000050073A3 (en) Caulobacter lps immunoadjuvant
BR9912067A (pt) Composição liofilizada, composição de vacina composta e aquosa composta da composição liofilizada, composição de vacina, método de imunização de um vertebrado através de vacinação, método para a preparação de uma composição liofilizada e de uma suspensão coloidal aquosa
SG147465A1 (en) Vaccine
WO2004020585A3 (en) Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
DK1401492T3 (da) LTB4 som vaccineadjuvans
BRPI0417880A (pt) vacina de combinação para a proteção de aves domésticas contra ornithobacterium rhinotracheale, uso de uma cepa de ornithobacterium rhinotracheale superatenuada viva e um vìrus de aves domésticas atenuado, método para a preparação de uma vacina de combinação, e, kit de vacinação
WO2004032959A3 (en) Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
DK1204420T3 (da) Trehaloseproducerende prokaryotiske celler som vacciner
UA67250A (en) Strain bovinae herpesvirus-1 "moldavian" for the preparation of vaccines and diagnosticums

Legal Events

Date Code Title Description
FA Abandonment or withdrawal